Dose escalation study of D2C7-IT administered intratumorally via convection-enhanced delivery for recurrent malignant glioma.
Publication
, Conference
Desjardins, A; Randazzo, D; Chandramohan, V; Peters, KB; Johnson, MO; Threatt, S; Herndon, JE; Boulton, S; Healy, P; Lipp, E; Fecci, P ...
Duke Scholars
Location
The West Coast of Norway
Conference Name
22nd International Conference on Brain Tumor Research and Therapy
Citation
APA
Chicago
ICMJE
MLA
NLM
Desjardins, A., Randazzo, D., Chandramohan, V., Peters, K. B., Johnson, M. O., Threatt, S., … Bigner, D. (n.d.). Dose escalation study of D2C7-IT administered intratumorally via convection-enhanced delivery for recurrent malignant glioma. Presented at the 22nd International Conference on Brain Tumor Research and Therapy, The West Coast of Norway.
Desjardins, Annick, Dina Randazzo, V. Chandramohan, Katherine B. Peters, Margaret O. Johnson, Steve Threatt, James E. Herndon, et al. “Dose escalation study of D2C7-IT administered intratumorally via convection-enhanced delivery for recurrent malignant glioma.,” n.d.
Desjardins A, Randazzo D, Chandramohan V, Peters KB, Johnson MO, Threatt S, et al. Dose escalation study of D2C7-IT administered intratumorally via convection-enhanced delivery for recurrent malignant glioma. In.
Desjardins A, Randazzo D, Chandramohan V, Peters KB, Johnson MO, Threatt S, Herndon JE, Boulton S, Healy P, Lipp E, Fecci P, Sampson J, Friedman A, Friedman H, Ashley D, Bigner D. Dose escalation study of D2C7-IT administered intratumorally via convection-enhanced delivery for recurrent malignant glioma.
Location
The West Coast of Norway
Conference Name
22nd International Conference on Brain Tumor Research and Therapy